JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kudoh, A.
Right arrow Articles by Takazawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kudoh, A.
Right arrow Articles by Takazawa, T.
Related Collections
Right arrow Cardiovascular
Right arrow Pharmacology
Anesth Analg 2002;94:552-557
© 2002 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Ketamine Suppresses Norepinephrine-Induced Inositol 1,4,5-Trisphosphate Formation Via Pathways Involving Protein Kinase C

Akira Kudoh, MD*, Emiko Kudoh, MD{dagger}, Hiroshi Katagai, MD*, and Tomoko Takazawa, MD*

Departments of *Anesthesiology and {dagger}Pediatrics, Hirosaki National Hospital, Hirosaki, Japan

Address correspondence and reprint requests to Akira Kudoh, MD, Department of Anesthesiology, Hirosaki National Hospital, 1 Tominocho, Hirosaki 036-8545, Aomori, Japan.

Inositol 1,4,5-trisphosphate (IP3) is not only involved in the physiologic regulation of excitation-contraction coupling, but could also play a role in cardiac pathophysiology. We investigated the mechanism of ketamine modulation of norepinephrine (NE)-induced IP3 formation in neonatal rat cardiomyocytes. Ketamine 1 and 10 µM significantly decreased the IP3 response to 1 µM NE by 27% and 43%, respectively. One micromolar TMB-8 (an intracellular calcium antagonist) produced 42% more decreases in IP3 production than produced by ketamine alone. One hundred micromolar anthranilic acid (a phospholipase A2 inhibitor) significantly decreased NE (1 µM)-induced IP3 formation, and the inhibition was further enhanced by ketamine. Ten micromolar U 73122 (a phospholipase C inhibitor) did not significantly affect NE-induced IP3 in the presence or absence of ketamine. One micromolar ketamine significantly inhibited staurosporine (a nonselective protein kinase C antagonist)-, bisindolylmaleimide (a selective protein kinase C antagonist)-, and wortmannin (a phosphatidylinositide 3-kinase antagonist)-stimulated IP3 formation. In conclusion, ketamine suppresses NE-induced IP3 production, and the inhibition is caused through pathways including protein kinase C and a decrease in intracellular Ca2+ concentrations.

IMPLICATIONS: Ketamine inhibits norepinephrine-induced inositol 1,4,5-triphosphate formation in a dose-dependent manner via pathways that involve protein kinase C and a decrease in intracellular Ca2+ concentrations.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
Y. Shiga, K. Minami, K. Segawa, Y. Uezono, M. Shiraishi, T. Sata, C. Yamamoto, and K. Sung-Teh
The Inhibition of Aortic Smooth Muscle Cell Proliferation by the Intravenous Anesthetic Ketamine
Anesth. Analg., November 1, 2004; 99(5): 1408 - 1412.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.